This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.


  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit Jul. 12, 2012

   Home   Mission/Vision    Membership    Corporate Membership    CME/CEU    JMCM    Contact Us

Click Here to view the Journal of Managed Care Medicine

Online CME/CEU Programs
Multiple Myeloma: An Update on Diagnostic and Treatment Strategies

Advanced Treatment of Osteoporosis in Postmenopausal Women

Decreasing the Cost Burden of Fibromyalgia with Early Diagnosis and Management


Announcing the NAMCP Medical Directors Lung Cancer Resource Center. Click here to visit the website.

Be sure to check out the study results of Verinata's Non-Invasive Prenatal Technology. Click here to view the press release.

Click here to check out the "Latest in Clinical Nutrition" DVD available for purchase now!

Fall Managed Care Forum
November 8-9
Bellagio Hotel

 



 Genomics

Genetic test changes game in cancer prognosis
The New York Times    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A new test identifies one of two gene patterns in eye melanomas. Almost everyone in Class 1 — roughly half of patients — is cured when the tumor is removed. As for those in Class 2, 80 to 90 percent will die within five years. No test has ever been so accurate in predicting cancer outcomes, researchers said. While for now the ocular melanoma test is in a class by itself, cancer researchers say it is a taste of what may be coming as they continue to investigate the genes of cancer cells. More

What is the Health Economic Impact of a Non-Invasive Prenatal Test?

Learn About Bridgehead International’s report, authored by Susan Garfield, on the clinical and economic utility of this test in this quarter’s JMCM, entitled “Clinical and Cost Consequences of Incorporating a Novel Non-Invasive Prenatal Test into the Diagnostic Pathway for Fetal Trisomies.


Genome study highlights risk factor for multiple sclerosis
Nature    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Like diabetes, most forms of cancer and other common diseases, there is no single gene that causes the autoimmune condition multiple sclerosis. Dozens of genetic variations act in concert with environmental factors to cause the debilitating neurological disease. Yet a single genetic variant may explain why drugs that treat other autoimmune diseases tend to make MS symptoms worse, and could identify other MS patients who might benefit from the therapies. More

A new treatment's promise brings heartbreaking ups and downs
The New York Times    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Scientists had compared the entire genetic sequences of the tumor cells invading Beth McDaniel's body with those in her healthy cells, searching for mutated tumor genes that could be thwarted by drugs approved for other cancers or even other diseases. That had led them to give her an expensive drug approved just a month earlier for melanoma patients. In theory, the drug should have killed her. Instead, it seemed to have halted or even reversed her cancer. More

 Biotech/Diagnostics/Personalized Medicine


FDA approves genetic test for use with cancer drug
The Wall Street Journal    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The Food and Drug Administration approved a genetic test made by Qiagen N.V. aimed at determining which colon cancer patients would benefit from the cancer drug Erbitux, the company said. Erbitux is approved to treat a certain group of patients with advanced colon cancer as well as head and neck cancer. More

CARDIODX®

Your patient's blood doesn't tell you that they will get tired walking the dog. Or that they've had heartburn for the past 2 weeks. But it can tell you whether or not obstructive CAD is what's causing their symptoms. You may not need to go deeper than the blood to know what's happening. MORE


New devices improve diabetes control
WebMD Health News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
By combining insulin pumps with continuous blood sugar sensors, people with diabetes get better blood sugar control than those using finger-stick testing and insulin shots, new research suggests. The findings come from an analysis of studies comparing new technologies to traditional methods for monitoring and controlling blood sugar. More


Nursing@
Georgetown


Nursing@Georgetown is a Master’s in Nursing program delivered online by Georgetown University’s renowned School of Nursing & Health Studies.
MORE
Our activities touch many lives
AstraZeneca is a global, innovation-driven, integrated biopharmaceutical company. We discover, develop, manufacture and market prescription medicines for cancer, cardiovascular, gastrointestinal and infection. MORE


 Regenerative Medicine


Arthritis stem cell jab 'could ease pain for millions'
Daily Mail    Share    Share on FacebookTwitterShare on LinkedinE-mail article
An injection of stem cells taken from body fat could one day help patients recover from crippling osteoarthritis. The treatment, which has been successfully trialed on animals, helps the body regrow tissue and cartilage that has been damaged by the degenerative condition. More

Diabetes drug may someday repair Alzheimer's damage
MyHealthNewsDaily via Fox News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The diabetes drug metformin may spur the growth of new brain cells, which could have benefits for Alzheimer's patients, a new Canadian study on mice suggests. The study showed metformin caused brain cells to divide, producing new cells. More

 Emerging Medical Technologies


Emergency caesarean simulator helps train doctors
BBC News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
An emergency caesarean simulator has been launched in the U.K. to help train doctors to perform complex C-sections. The "pregnant" abdomen, made from silicone and plastic, mimics advanced labor — where the baby's head gets stuck in the mother's pelvis. More

Ultra high-speed camera rapidly detects circulating tumor cells
Medgadget    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Quickly detecting circulating tumor cells would be a major boon for cancer diagnostics, but serious challenges persist because CTCs in infected blood are rarer than needles in haystacks. Visual microscopy is a good way of identifying CTCs, but millions of flowing cells have to be photographed very quickly, and researchers at UCLA have developed a new kind of camera to do just that. More

 Managed Healthcare News


Payment raise proposed for primary care providers
Healthcare Finance News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The Centers for Medicare & Medicaid Services is sending some sunshine in the direction of primary care providers. In a proposed rule, CMS is offering payment increases for family physicians and other primary care providers as well as proposals to better pay for the range of care primary care providers give patients. More

New obesity treatment guidelines herald coverage changes
Kaiser Health News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Recently revised guidelines from the U.S. Preventive Services Task Force recommend clinicians screen patients for obesity, which is defined as having a body mass index of 30 or higher. The revised guidelines strengthen the previous recommendations, experts say. It's unclear whether employers and insurers will welcome the change, though. More

 FDA: New Treatments and Technology


FDA announces new safety plan for opioid use
CNN    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The Food and Drug Administration has announced new safety measures for a class of opioid medication used to treat moderate to severe chronic pain. But if they fall into the wrong hands or are used for recreational purposes, these medications can cause serious harm, including overdose and death. More

HPV vaccine shows evidence of herd protection
The Medical News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The HPV vaccine not only has resulted in a decrease in human papillomavirus infection in immunized teens but also in teens that were not immunized. The study is believed to be the first to show a substantial decrease in HPV infection in a community setting as well as herd protection — a decrease in infection rates among unimmunized individuals that occurs when a critical mass of people in a community is immunized against a contagious disease. More

FAST FACTS
"According to the National Institute of Allergy and Infectious Diseases, community — or 'herd' — immunity occurs when even those not immunized get some level of protection when other members of the community are immunized against a contagion."
 

Genomics Biotech and Emerging Medical Technologies Institute eBrief
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Christine Kraly, Content Editor, 469.420.2685   
Contribute news

This edition of the Genomics Biotech and Emerging Medical Technologies Institute eBrief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
Recent issues
July 5, 2012
June 28, 2012
June 21, 2012
June 14, 2012



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063